Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

The European Organisation for the Research and Treatment of Cancer (EORTC) Cutaneous Lymphoma Task Force (CLTF) 2018 Congress was held in St. Gallen, Switzerland, from the 27–29th September.

Highlights include updates on the use of checkpoint inhibitors and antibody therapies for cutaneous T-cell lymphoma, the future outlook for ECP, convenient topical agents, and updates on PROCLIPI studies.

EORTC CLTF 2018

27–29 September 2018 | St. Gallen, Switzerland

EORTC CLTF 2018

27–29 September 2018 | St. Gallen, Switzerland

The European Organisation for the Research and Treatment of Cancer (EORTC) Cutaneous Lymphoma Task Force (CLTF) 2018 Congress was held in St. Gallen, Switzerland, from the 27–29th September.

Highlights include updates on the use of checkpoint inhibitors and antibody therapies for cutaneous T-cell lymphoma, the future outlook for ECP, convenient topical agents, and updates on PROCLIPI studies.